Abdullah Kars
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes (NCT07610213) | Abdullah Kars | 2027-01-01 |
Track Abdullah Kars automatically
Every clearance here is in the API, with alerts when new ones post.